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Sexually transmitted infection with an immune-escape mutant
hepatitis B virus (HBV) in an HBV-vaccinated individual with
acute HIV-HCV infection
Ingiliz, P; Krznaric, I; Behrendt, D; Baumgarten, A; Berg, T and Obermeier, M
Medical Center for Infectious Diseases, Berlin, Germany.
Immune pressure exerted on HBV by anti-HBV antibodies and long-term therapy with drugs that mutagenize the viral
polymerase gene can select for mutations in its surface gene, leading to vaccine escape and evasion from serological detection.
In general, these mutations are considered to be poorly transmissible. However, cases of HBV infection with vaccine-escape
mutant viruses have been reported in vaccinated individuals, mainly from high-prevalence regions of the world.The possibility of
an infection with HBV despite an effective vaccination may pose a major health issue, requiring a change in routine diagnostic
and screening programmes. Here, we report a case of a HBV vaccine escape mutant infection in an effectively vaccinated
individual.The patient was a 27-year old man who has sex with men (MSM) who presented in September 2011 for the first time
in a Berlin outpatient HIV clinic due to a newly diagnosed HIV infection. He was aware of several sexual high-risk contacts within
the past, but had a negative HIV and HCV antibody test (ELISA) in April 2011. He complained about slight fever, swollen cervical
and axillary lymph nodes and general muscle pain. The Western blot confirmed an HIV infection. The HIV viral load was 24,000
copies/mL, the CD4 count was 550/mm
3. His ALT levels were elevated to 10the upper limit of normal (ULN) and he was
additionally found to have acute HCV infection: The HCV viral load was 2 million IU/mL, the HCV genotype was 2c. Furthermore,
he was anti-HBc negative, HBsAG negative, and his anti-HBs level was 121 IU/L. He reported to have been vaccinated for HBV in
the past. Three months later, the patient was routinely retested. At this time point, his HBsAg turned out to be positive and
anti-HBs antibodies had vanished. His HBV viral load was 600 million IU/mL, and ALT had decreased to 2ULN. Population
sequencing revealed a genotype F and a S143L mutation in the surface gene consistent with a vaccine escape mutant HBV.
A retrospective analysis of the initial blood sample showed a HBV DNA of 90 IU/mL.
Conclusion
To our knowledge, this is the first report of a sexually transmitted HBV virus with vaccine-escape mutation in a vaccinated
individual. Despite a fairly high CD4 count, the transmission may have been promoted by a loss of immunity through an acute
HIV infection. Clinicians need to be aware of the possibility of HBV infections with mutant viruses.
Published 11 November 2012
Copyright: – 2012 Ingiliz P et al; licensee International AIDS Society.This is an open access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work
is properly cited.
Abstracts of the Eleventh International Congress on Drug Therapy in HIV Infection
Ingiliz P et al. Journal of the International AIDS Society 2012, 15(Suppl 4):18432
http://www.jiasociety.org/index.php/jias/article/view/18432 | http://dx.doi.org/10.7448/IAS.15.6.18432
1